Morgan Stanley maintains that India's long-term equity outlook is strong, despite recent market dips. Key factors include ...

Indias IT sector is facing significant challenges as stocks have plummeted due to recession fears in the US, AI competition, ...

A number of brokerage firms believe that India equities have turned attractive for the investors after the recent correction ...

Investors digested the latest tariff threat from President Donald Trump, while they pored through new U.S. inflation figures.

Apple has boosted India’s manufacturing sector after the tech giant shifted some assembly there. But Trump’s tariffs might ...

Morgan Stanley favours TCS over Infosys due to macroeconomic concerns and shifting tech cycles. Explore the more details.

Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.

Coforge shines in Morgan Stanley's midcap IT picks due to large deals and client growth. Discover why it's a preferred bet now!

Infosys dropped 4.3%, the top loser in the IT pack, after Morgan Stanley downgraded the stock from 'Overweight' to ...

U.S. stocks have suffered their sharpest selloff in months over recent days as investors have grown nervous that President ...

This will be the second South Korean company to tap the Indian stock market following the listing of Hyundai Motors India Ltd ...

The Indian arm of the Seoul-headquartered home appliances and electronics company could roll out its Rs 15,000 crore maiden ...